Pediatrix EVP Haddock files initial Form 3

Pediatrix Medical Group, Inc. executive David Haddock, who serves as EVP, General Counsel and Corporate Secretary, submitted an initial Form 3 insider ownership report.

Rhea-AI Filing Summary

Pediatrix Medical Group, Inc. executive David Haddock, who serves as EVP, General Counsel and Corporate Secretary, submitted an initial Form 3 insider ownership report. The filing lists no transactions or derivative positions, functioning as a baseline disclosure of his status as a reporting officer.

Key Terms

Form 3, EVP, GC & Corp Sec, reporting person

3 terms

Form 3 regulatory

"submitted an initial Form 3 insider ownership report"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

EVP, GC & Corp Sec financial

"officer_title": "EVP, GC & Corp Sec""

reporting person regulatory

"his status as a reporting officer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Pediatrix (MD) Form 3 filed by David Haddock show?

The Form 3 shows that executive David Haddock, EVP, General Counsel and Corporate Secretary of Pediatrix Medical Group, has filed his initial insider ownership report. It lists no transactions or derivative positions, serving as a baseline disclosure of his reporting status.

Did Pediatrix (MD) EVP David Haddock buy or sell shares in this Form 3?

No share purchases or sales are reported in this Form 3 filing. The transaction summary shows zero buy, sell, exercise, gift, tax withholding, or restructuring entries, indicating this is purely an initial ownership and reporting-status disclosure for the executive.

What role does David Haddock hold at Pediatrix (MD) in this Form 3?

David Haddock is identified as an officer of Pediatrix Medical Group with the title "EVP, GC & Corp Sec." This means he serves as Executive Vice President, General Counsel and Corporate Secretary, which makes him a reporting person subject to insider disclosure requirements.

Are there any derivative securities reported for Pediatrix (MD) EVP David Haddock?

No derivative securities are reported for David Haddock in this Form 3. The derivativeSummary section is empty and the transaction summary shows zero derivative transactions, so the filing does not list options, warrants, or other derivative positions for this executive.

Does the Pediatrix (MD) Form 3 indicate net insider buying or selling?

The Form 3 indicates no net insider buying or selling activity for David Haddock. The transaction summary shows zero shares bought or sold and a net buy/sell direction of "neutral," confirming there were no reported transactions associated with this initial statement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Haddock David

(Last) (First) (Middle)

1301 CONCORD TERRACE

(Street)

SUNRISE FLORIDA 33323

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/22/2026

3. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC & Corp Sec

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

See Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ David Haddock	06/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)